On Air Now

Current Show

WSAU Feedback   8:00 AM - 9:00 AM

Call WSAU Feedback at 715-845-2155.

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
40° Feels Like: 40°
Wind: ESE 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Sunny 61°

Tonight

Partly Cloudy 42°

Tomorrow

PM Rain 65°

Alerts

GSK says heart drug darapladib fails in second late-stage trial

LONDON (Reuters) - GlaxoSmithKline said its drug darapladib had not reduced heart attacks or other major events in patients with acute coronary syndrome, marking another disappointment for the innovative heart medicine.

Darapladib had already failed in a late-stage trial for patients with well-treated heart disease. [ID:nL1N0MR078]

Patrick Vallance, GSK’s President of Pharmaceuticals R&D, said he was disappointed that the outcome of the second phase III study did not support a regulatory submission.

"In the study, darapladib did not achieve the primary endpoint of a reduction of major coronary events versus placebo when added to standard of care," the British company said on Tuesday.

(Reporting by Paul Sandle; editing by Kate Holton)

Comments